Low TRIM21 signal in Sjögren's: biomarker or analytical interference? - Authors' reply.

Behrendt R, Ng WF, Hunt D.

Open source

DOI
10.1016/s2665-9913(26)00290-0
Published
2026-11-01
Container
Lancet Rheumatol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2665-9913-26-00290-0,
  title = {Low TRIM21 signal in Sjögren's: biomarker or analytical interference? - Authors' reply.},
  author = {Behrendt R and  Ng WF and  Hunt D.},
  year = {2026},
  journal = {Lancet Rheumatol},
  doi = {10.1016/s2665-9913(26)00290-0},
  url = {https://doi.org/10.1016/s2665-9913(26)00290-0}
}

RIS

TY  - JOUR
TI  - Low TRIM21 signal in Sjögren's: biomarker or analytical interference? - Authors' reply.
AU  - Behrendt R
AU  -  Ng WF
AU  -  Hunt D.
PY  - 2026
JO  - Lancet Rheumatol
DO  - 10.1016/s2665-9913(26)00290-0
UR  - https://doi.org/10.1016/s2665-9913(26)00290-0
ER  - 

APA

R, B., WF, N., & D., H. (2026). Low TRIM21 signal in Sjögren's: biomarker or analytical interference? - Authors' reply.. Lancet Rheumatol. https://doi.org/10.1016/s2665-9913(26)00290-0

Source records